Skip to main content

Table 2 TESTsmART study outcomes

From: Incentivizing appropriate malaria case management in the private sector: a study protocol for two linked cluster randomized controlled trials to evaluate provider- and client-focused interventions in western Kenya and Lagos, Nigeria

Type Name Client sample Client-level outcome Arm-level summary Arm-level formula
Primary ACT consumption by true malaria cases All clients who purchased an ACT 1 = positive malaria testa and purchases ACT
0 = otherwise
Proportion of ACTs that are sold to malaria test-positivea clients \( \frac{\#\mathrm{clients}\ \mathrm{who}\ \mathrm{purchased}\ \mathrm{ACT}\ \mathrm{and}\ \mathrm{tested}\ \mathrm{positive}}{\#\mathrm{clients}\ \mathrm{who}\ \mathrm{purchased}\ \mathrm{ACT}} \)
Secondary Use of malaria rapid diagnostic test All suspected malaria casesb 1 = tested with mRDT
0 = otherwise
Proportion of suspected malaria cases that receives a malaria test \( \frac{\#\mathrm{suspected}\ \mathrm{malaria}\ \mathrm{cases}\ \mathrm{tested}\ \mathrm{with}\ \mathrm{mRDT}}{\#\mathrm{suspected}\ \mathrm{malaria}\ \mathrm{cases}} \)
Adherence to mRDT result All clients who were tested with mRDT 1 = positive malaria test and purchases ACT OR negative malaria test and did not purchase any AM
0 = otherwise
Proportion of malaria tested clients whose treatment adhered to test results \( {\displaystyle \begin{array}{c}\#\mathrm{clients}\ \mathrm{that}\ \mathrm{tested}\ \mathrm{positive}\ \mathrm{with}\ \mathrm{mRDT}\ \mathrm{and}\ \mathrm{purchase}\mathrm{d}\ \mathrm{ACT}+\\ {}\frac{\#\mathrm{clients}\ \mathrm{that}\ \mathrm{tested}\ \mathrm{negative}\ \mathrm{with}\ \mathrm{mRDT}\ \mathrm{and}\ \mathrm{d}\mathrm{id}\ \mathrm{not}\ \mathrm{purchase}\ \mathrm{AM}}{\#\mathrm{clients}\ \mathrm{tested}\ \mathrm{with}\ \mathrm{mRDT}}\end{array}} \)
Appropriate case mgmt All suspected malaria casesb 1 = positive malaria test and purchases ACT OR negative malaria test and did not purchase any AM
0 = otherwise
Proportion of suspected malaria cases that are managed appropriately \( {\displaystyle \begin{array}{c}\#\mathrm{clients}\ \mathrm{that}\ \mathrm{tested}\ \mathrm{positive}\ \mathrm{with}\ \mathrm{mRDT}\ \mathrm{and}\ \mathrm{purchase}\mathrm{d}\ \mathrm{ACT}+\\ {}\frac{\#\mathrm{clients}\ \mathrm{that}\ \mathrm{tested}\ \mathrm{negative}\ \mathrm{with}\ \mathrm{mRDT}\ \mathrm{and}\ \mathrm{d}\mathrm{id}\ \mathrm{not}\ \mathrm{purchase}\ \mathrm{AM}}{\#\mathrm{suspected}\ \mathrm{malaria}\ \mathrm{cases}}\end{array}} \)
ACT use among the untested All untested clients 1 = purchased ACT
0 = otherwise
Proportion of untested clients taking ACT \( \frac{\#\mathrm{untested}\ \mathrm{clients}\ \mathrm{who}\ \mathrm{purchased}\ \mathrm{ACT}\ }{\#\mathrm{untested}\ \mathrm{clients}\ } \)
  1. amRDT+ based on RDT conducted at retail outlet or positive by test conducted outside of the retail outlet when documentation is provided
  2. bA “suspected malaria case” is any client who was tested with an mRDT or was untested but purchased any antimalarial (AM)